8102
-
Therapeutics and Clinical Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Therapeutics and Clinical Risk Management
(2,215,702) Views
Editor in Chief Professor Garry Walsh
1178-203X
Evaluation of patient care interventions and recommendations by a transitional care pharmacist
K Bruce Bayley, Lucy A Savitz, Teresa Maddalone, Stephen E Stoner, Jacquelyn S Hunt, Robert Wells
Therapeutics and Clinical Risk Management 2007, 3:695-703
04 October 2007
Ondansetron oral disintegrating tablets for the prevention of postoperative vomiting in children undergoing strabismus surgery
Deborah S Wagner, Virginia Gauger, Devi Chiravuri, Kristin Faust
Therapeutics and Clinical Risk Management 2007, 3:691-694
04 October 2007
How should we measure medication adherence in clinical trials and practice?
Jeannie K Lee, Karen A Grace, Terri G Foster, Monica J Crawley, Goldina I Erowele, et al
Therapeutics and Clinical Risk Management 2007, 3:685-690
04 October 2007
Bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: the potential role of daptomycin
David M Bamberger
Therapeutics and Clinical Risk Management 2007, 3:675-684
04 October 2007
A review of lapatinib ditosylate in the treatment of refractory or advanced breast cancer
Michael H Nelson, Christian R Dolder
Therapeutics and Clinical Risk Management 2007, 3:665-673
04 October 2007
A review of esomeprazole in the treatment of gastroesophageal reflux disease (GERD)
Evangelos Kalaitzakis, Einar Björnsson
Therapeutics and Clinical Risk Management 2007, 3:653-663
04 October 2007
Review of tipranavir in the treatment of drug-resistant HIV
Hendrik Streeck, Jürgen Kurt Rockstroh
Therapeutics and Clinical Risk Management 2007, 3:641-651
04 October 2007
Prevention of shingles: safety and efficacy of live zoster vaccine
Dianna Quan, Randall J Cohrs, Ravi Mahalingam, Donald H Gilden
Therapeutics and Clinical Risk Management 2007, 3:633-639
04 October 2007
Using risk management files to identify and address causative factors associated with adverse events in pediatrics
Paul D Hain, James W Pichert, Gerald B Hickson, Sandra H Bledsoe, David Hamming, et al
Therapeutics and Clinical Risk Management 2007, 3:625-631
04 October 2007
A review of the use of adapalene for the treatment of acne vulgaris
Suleyman Piskin, Erol Uzunali
Therapeutics and Clinical Risk Management 2007, 3:621-624
04 October 2007
A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma
Gennaro D’Amato, Antonello Salzillo. Amedeo Piccolo, Maria D’Amato, Gennaro Liccardi
Therapeutics and Clinical Risk Management 2007, 3:613-619
04 October 2007
Time for an active antiviral therapy for hepatitis B: An update on the management of hepatitis B virus infection
Hee Bok Chae, Hie-Won Hann
Therapeutics and Clinical Risk Management 2007, 3:605-612
04 October 2007
Clinical studies with oral lipid based formulations of poorly soluble compounds
Dimitrios G Fatouros, Ditte M Karpf, Flemming S Nielsen, Anette Mullertz
Therapeutics and Clinical Risk Management 2007, 3:591-604
04 October 2007
Treatment of premenstrual dysphoric disorder (PMDD) with a novel formulation of drospirenone and ethinyl estradiol
Domenico De Berardis, Nicola Serroni, Rosa Maria Salerno, Filippo Maria Ferro
Therapeutics and Clinical Risk Management 2007, 3:585-590
04 October 2007
The renaissance of fixed dose combinations: Combivir
Simon D Portsmouth, Christopher J Scott
Therapeutics and Clinical Risk Management 2007, 3:579-583
04 October 2007
Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results
Marco Metra, Savina Nodari, Tania Bordonali, Patrizia Milani, Carlo Lombardi, et al
Therapeutics and Clinical Risk Management 2007, 3:569-578
04 October 2007
Reflections on adjuvant treatment of gastric cancer
Albert Abad, José Luis Manzano, Cristina Martí
Therapeutics and Clinical Risk Management 2007, 3:563-567
04 October 2007
Lenalidomide: a brief review of its therapeutic potential in myelodysplastic syndromes
Aristoteles A N Giagounidis, Ulrich Germing, Sabine Haase, Carlo Aul
Therapeutics and Clinical Risk Management 2007, 3:553-562
04 October 2007
Review of thalidomide in the treatment of newly diagnosed multiple myeloma
Federica Cavallo, Mario Boccadoro, Antonio Palumbo
Therapeutics and Clinical Risk Management 2007, 3:543-552
04 October 2007
Role of posaconazole in the management of oropharyngeal and esophageal candidiasis
Jose A Vazquez
Therapeutics and Clinical Risk Management 2007, 3:533-542
04 October 2007
A randomized study examining the effect of 3 SSRI on premature ejaculation using a validated questionnaire
Mohamed Arafa, Rany Shamloul
Therapeutics and Clinical Risk Management 2007, 3:527-531
04 October 2007
Drug forecast – the peptide deformylase inhibitors as antibacterial agents
David R P Guay
Therapeutics and Clinical Risk Management 2007, 3:513-525
04 October 2007
Current treatment options in the management of chronic prostatitis
Alain Jean Duclos, Chun-Te Lee, Daniel Arthur Shoskes
Therapeutics and Clinical Risk Management 2007, 3:507-512
04 October 2007
Editorial || FREE PAPER ||
Garry M Walsh
Therapeutics and Clinical Risk Management 2007, 3:505-506
04 October 2007
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
